PSNCBAM‐1, a novel allosteric antagonist at cannabinoid CB₁ receptors with hypophagic effects in rats

Abstract

PSNCBAM-1 exerted its effects through selective allosteric modulation of the CB1 receptor. The acute effects on food intake and body weight induced in rats provide a first report of in vivo activity for an allosteric CB1 receptor antagonist.